Dyne Therapeutics Inc (DYN)

EBITDA Margin

-299.25%

TTM · Period ending:

DYN logo

DYN EBITDA Margin

Latest reported-299.25%
DYN TTM EBITDA Margin (25.54% → -299.25%)
High-resolution chart · PNG

DYN ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Dyne Therapeutics Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-299.2494%
-180.4761%
-128.4936%
23.8095%
139.5034%
124.5677%
82.1559%
11.9327%
-39.1414%
-8.0782%
22.4544%
8.5271%
15.0518%
9.9423%
7.4212%
8.9774%
9.7317%
13.7413%
15.1455%
14.0449%
80.029%
61.4458%
4.5122%
7.0047%
-179.8596%
-231.178%
-128.0827%
-90.7256%
33.3148%
33.3009%
46.5891%
41.4897%
26.8399%
27.2512%
-0.6783%
1.094%
9.922%
13.438%
31.7879%
25.4156%
21.8804%
28.1274%
25.5448%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.